摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-{1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-N-{[2-(morpholino)-5-(trifluoromethyl)phenyl]methyl}-5-[2-(methylsulfonyl)ethoxy]pyrimidin-2-amine | 1072907-19-7

中文名称
——
中文别名
——
英文名称
N-{1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-N-{[2-(morpholino)-5-(trifluoromethyl)phenyl]methyl}-5-[2-(methylsulfonyl)ethoxy]pyrimidin-2-amine
英文别名
N-[1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-5-(2-methylsulfonylethoxy)-N-[[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]methyl]pyrimidin-2-amine
N-{1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-N-{[2-(morpholino)-5-(trifluoromethyl)phenyl]methyl}-5-[2-(methylsulfonyl)ethoxy]pyrimidin-2-amine化学式
CAS
1072907-19-7
化学式
C29H29F9N4O4S
mdl
——
分子量
700.625
InChiKey
JTFRFRCOURIFCF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.8
  • 重原子数:
    47
  • 可旋转键数:
    10
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    93.2
  • 氢给体数:
    0
  • 氢受体数:
    17

文献信息

  • NOVEL PYRIMIDINE COMPOUND HAVING DIBENZYLAMINE STRUCTURE AND MEDICAMENT COMPRISING THE SAME
    申请人:OHGIYA Tadaaki
    公开号:US20090082352A1
    公开(公告)日:2009-03-26
    A compound represented by the following general formula (I), wherein R 1 , R 2 , R 3 , R 4 and R 5 represent hydrogen atom, a halo(lower alkyl) group, cyano group and the like, R 6 represents an alkyl group, a cycloalkyl group and the like, R 7 , R 8 , R 9 and R 10 represent hydrogen atom, a halogen atom, a lower alkyl group, a halo(lower alkyl) group and the like, R 11 and R 12 represent hydrogen atom, a lower alkyl group, a (lower cycloalkyl) (lower alkyl) group and the like, and R 13 represents hydrogen atom, a halogen atom, a lower alkoxy group and the like, which has potent inhibitory activity on cholesterol ester transfer protein (CETP).
    一个由以下通用公式(I)表示的化合物,其中R1、R2、R3、R4和R5代表氢原子、卤素(低烷基)基团、基团等,R6代表烷基基团、环烷基基团等,R7、R8、R9和R10代表氢原子、卤素原子、低烷基基团、卤素(低烷基)基团等,R11和R12代表氢原子、低烷基基团、(低环烷基)(低烷基)基团等,R13代表氢原子、卤素原子、低烷氧基团等,具有对胆固醇酯转移蛋白(CETP)具有强大抑制活性的化合物。
  • NOVEL PYRIMIDINE COMPOUND HAVING DIBENZYLAMINE STRUCTURE, AND MEDICINE COMPRISING THE COMPOUND
    申请人:Kowa Company. Ltd.
    公开号:EP2149563A1
    公开(公告)日:2010-02-03
    A compound represented by the following general formula (I), wherein R1, R2, R3, R4 and R5 represent hydrogen atom, a halo(lower alkyl) group, cyano group and the like, R6 represents an alkyl group, a cycloalkyl group and the like, R7, R8, R9 and R10 represent hydrogen atom, a halogen atom, a lower alkyl group, a halo(lower alkyl) group and the like, R11 and R12 represent hydrogen atom, a lower alkyl group, a (lower cycloalkyl)(lower alkyl) group and the like, and R13 represents hydrogen atom, a halogen atom, a lower alkoxy group and the like, which has potent inhibitory activity on cholesterol ester transfer protein (CETP).
    由以下通式(I)代表的化合物,其中 R1、R2、R3、R4 和 R5 代表氢原子、卤代(低级烷基)基团、基等,R6 代表烷基、环烷基等,R7、R8、R9 和 R10 代表氢原子、卤素原子、低级烷基、卤代(低级烷基)基团等,R11 和 R12 代表氢原子、低级烷基、(低级环烷基)(低级烷基)基团等,以及 R13 代表卤代(低级环烷基)(低级烷基)基团等、R11和R12代表氢原子、低级烷基、(低级环烷基)(低级烷基)基团等,R13代表氢原子、卤素原子、低级烷氧基等,它们对胆固醇酯转移蛋白(CETP)具有强效抑制活性。
  • US7659271B2
    申请人:——
    公开号:US7659271B2
    公开(公告)日:2010-02-09
查看更多